In this third and final segment of our program on degenerative mitral valve disease in dogs, we turn our focus to non-medical therapies for treating affected dogs.
Our presenters create an understanding of the utility of left atrial decompression (LAD) and transcatheter edge-to-edge repair (TEER) in managing affected dogs and factors that influence patient selection for these procedures. We then discuss the option of open-heart surgery and patient selection for open-heart mitral valve repair.
Running time: 1 hr 20 mins
Approved for 1.25 hrs of CE credit by AAVSB RACE and NY State
You might also like
Hemangiosarcoma - What We Know And How That's Changing The Paradigm Of Treatment And Prevention
11/13/2024
Hemangiosarcoma is a malignant tumor and, historically, associated with a poor long term prognosis....
Read
More
The Current Thinking About What Cancer Is And Its Possible Causes
10/23/2024
Cancer is a term that is often shrouded in uncertainty and fear, but gaining a clear understanding o...
Read
More
Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition
09/17/2024
In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...
Read
More
Mastering IMHA In Dogs - Part I: Approaches To Diagnosis And Standard Management
07/23/2024
This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in do...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Quality Of Life And End Of Life Considerations
07/09/2024
The focus of this session is on maximizing the quality of life of dogs with chronic kidney disease (...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog: Understanding Proteinuria And CKD And How This Changes The Diagnostic Or Treatment Approach
07/02/2024
In previous sessions of this series on chronic kidney disease in dogs there was brief discussion of...
Read
More
